Resimac Group Limited (ASX:RMC)
Australia · Delayed Price · Currency is AUD | Market Cap | 352.11M |
| Revenue (ttm) | 133.45M |
| Net Income (ttm) | 27.85M |
| Shares Out | 395.63M |
| EPS (ttm) | 0.07 |
| PE Ratio | 12.83 |
| Forward PE | 8.84 |
| Dividend | 0.07 (7.69%) |
| Ex-Dividend Date | Jun 5, 2025 |
| Volume | 73,950 |
| Average Volume | 76,588 |
| Open | 0.9150 |
| Previous Close | 0.9100 |
| Day's Range | 0.8900 - 0.9200 |
| 52-Week Range | 0.8100 - 1.0500 |
| Beta | 1.55 |
| RSI | 53.00 |
| Earnings Date | Aug 25, 2025 |
About Resimac Group
Resimac Group Limited provides residential mortgage and asset finance lending products in Australia and New Zealand. The company operates through Home Loan Lending business, New Zealand Lending, and Asset Finance Lending segments. It offers prime and specialist lending products; SME/commercial finance products; and home and car loans. The company also provides mortgage originator, trustee, lender, and mortgage manager and broker services; consumer and commercial lending; and LMI captive insurer services. In addition, it acts as a trust manager ... [Read more]
Financial Performance
In 2024, Resimac Group's revenue was 147.27 million, a decrease of -30.96% compared to the previous year's 213.30 million. Earnings were 34.59 million, a decrease of -47.94%.
Financial StatementsNews
ASX 200 LIVE: Mayne Pharma shares plunge; CBA hits record; JHX sales, earnings slip amid AZEK buy; ASIC sues Resimac, sharemarket rises
Shares lift; CBA resets intraday record, tops $176; Mayne Pharma-Cosette tie-up hangs in balance; Nufarm plunges; James Hardie drops 5pc. Follow live.